Taiwan · Delayed Price · Currency is TWD Sunhawk Vision Biotech Statistics
Total Valuation
TPEX:7759 has a market cap or net worth of TWD 5.49 billion. The enterprise value is 5.04 billion.
| Market Cap | 5.49B |
| Enterprise Value | 5.04B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:7759 has 70.07 million shares outstanding. The number of shares has increased by 7.28% in one year.
| Current Share Class | 70.07M |
| Shares Outstanding | 70.07M |
| Shares Change (YoY) | +7.28% |
| Shares Change (QoQ) | +10.67% |
| Owned by Insiders (%) | 22.80% |
| Owned by Institutions (%) | n/a |
| Float | 54.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 10.01 |
| P/TBV Ratio | 11.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -31.13 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -34.99 |
Financial Position
The company has a current ratio of 23.31, with a Debt / Equity ratio of 0.01.
| Current Ratio | 23.31 |
| Quick Ratio | 22.01 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.05 |
| Interest Coverage | -801.42 |
Financial Efficiency
Return on equity (ROE) is -38.75% and return on invested capital (ROIC) is -23.36%.
| Return on Equity (ROE) | -38.75% |
| Return on Assets (ROA) | -22.86% |
| Return on Invested Capital (ROIC) | -23.36% |
| Return on Capital Employed (ROCE) | -29.04% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TPEX:7759 has paid 108,000 in taxes.
| Income Tax | 108,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 74.77 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 57.29 |
| Average Volume (20 Days) | 140,113 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -160.28M |
| Pretax Income | -162.40M |
| Net Income | -161.87M |
| EBITDA | -158.93M |
| EBIT | -160.28M |
| Earnings Per Share (EPS) | -2.45 |
Balance Sheet
The company has 455.22 million in cash and 7.61 million in debt, giving a net cash position of 447.61 million or 6.39 per share.
| Cash & Cash Equivalents | 455.22M |
| Total Debt | 7.61M |
| Net Cash | 447.61M |
| Net Cash Per Share | 6.39 |
| Equity (Book Value) | 548.16M |
| Book Value Per Share | 7.82 |
| Working Capital | 469.70M |
Cash Flow
In the last 12 months, operating cash flow was -143.40 million and capital expenditures -620,000, giving a free cash flow of -144.02 million.
| Operating Cash Flow | -143.40M |
| Capital Expenditures | -620,000 |
| Free Cash Flow | -144.02M |
| FCF Per Share | -2.06 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:7759 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.28% |
| Shareholder Yield | n/a |
| Earnings Yield | -2.95% |
| FCF Yield | -2.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |